eglumetad has been researched along with Brain Ischemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, A; Hicks, CA; Lodge, D; Monn, JA; O'Neill, MJ | 1 |
| Lam, AG; Lodge, D; McCulloch, J; Monn, JA; Schoepp, DD; Soriano, MA | 1 |
| Bond, A; Hicks, CA; Lodge, D; Monn, JA; O'Neill, MJ; Ragumoorthy, N; Ward, MA | 1 |
| O'Neill, MJ | 1 |
4 other study(ies) available for eglumetad and Brain Ischemia
| Article | Year |
|---|---|
Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia.
Topics: Animals; Brain Ischemia; Bridged Bicyclo Compounds; Disease Models, Animal; Excitatory Amino Acid Agonists; Gerbillinae; Male; Neuroprotective Agents; Receptors, Metabotropic Glutamate | 1998 |
Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia.
Topics: Animals; Brain; Brain Ischemia; Bridged Bicyclo Compounds; Cerebral Infarction; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Male; Neuroprotective Agents; Rats; Rats, Inbred F344; Receptors, Metabotropic Glutamate | 1998 |
LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.
Topics: Amino Acids; Animals; Brain Ischemia; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Excitatory Amino Acid Agonists; Gerbillinae; Hippocampus; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stereoisomerism | 1999 |
Pharmacology and neuroprotective actions of mGlu receptor ligands.
Topics: Amino Acids; Brain; Brain Ischemia; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Glycine; Hippocampus; Humans; Kainic Acid; Ligands; Nerve Degeneration; Neuroprotective Agents; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2001 |